We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Biomarkers Prove Role of Food for Diabetics

By LabMedica International staff writers
Posted on 27 Sep 2017
Print article
Image: Gas chromatography-tandem mass spectrometry GCMS TQ-8030 GC-MS/MS (Photo courtesy of Shimadzu).
Image: Gas chromatography-tandem mass spectrometry GCMS TQ-8030 GC-MS/MS (Photo courtesy of Shimadzu).
Diet is frequently associated with both the development and prevention of type 2 diabetes (T2D), but there is a lack of objective tools for assessing the relation between diet and T2D.

A pioneering method has demonstrated its potential in a large study, showing that metabolic fingerprints from blood samples could render important new knowledge on the connection between food and health and that diet is one of the strongest predictors of type 2 diabetes risk in older women.

Scientists at the Chalmers University of Technology (Gothenburg, Sweden) measured dietary biomarkers were measured in plasma from 64-y-old Swedish women with different glucose tolerance status (GTS). There were 190 with normal glucose tolerance (NGT), 209 with impaired glucose tolerance (IGT), and 230 diagnosed with diabetes. The same subjects were followed up after five years to determine changes in glucose tolerance (167 for NGT, 174 for IGT, and 159 for diabetes).

The blood samples were analyzed, using gas chromatography-tandem mass spectrometry metabolomics where a unique metabolic fingerprint, including many different diet biomarkers, could be linked to each woman at the specific time the sample was taken. Samples were injected onto a Shimadzu GCMS TQ-8030 GC-MS/MS and both scan and multiple reaction monitoring data was collected for further data analysis. Using this method it was possible for the first time to objectively determine the impact of key dietary components on future type 2 diabetes risks, as well as to find differences in dietary patterns between women with and without type 2 diabetes.

The team reported that of the 10 dietary biomarkers analyzed, β-alanine (beef), alkylresorcinols C17 and C19 (whole-grain wheat and rye), eicosapentaenoic acid (fish), 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) (fish), linoleic acid, oleic acid and α-tocopherol (margarine and vegetable oil) were associated with GTS. CMPF and α-tocopherol were inversely associated with future T2D development.

Alastair B. Ross, PhD, an associate professor and lead author of the study, said, “The new method has allowed us to measure several markers of diet and nutrient status at the same time in a large number of people, which we believe is the first time this has been done. New methods such as ours will help to improve how we measure diet and understand in more detail how dietary patterns relate to disease.” The study was published on September 13, 2017, in the American Journal of Clinical Nutrition.

Related Links:
Chalmers University of Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.